NICE’s 2023 daridorexant appraisal added a medicine option for defined circumstances while retaining CBT-I as standard initial care. Regulatory approval is not the same as unrestricted NHS eligibility.
Sleep difficulties were often described in older classifications as either primary insomnia or insomnia secondary to another illness. Current clinical thinking gives more attention to insomnia as a problem that may need treatment in its own right, even when pain, depression or another condition is also present.
Distinguishing problems of sleep timing, amount and unusual events during sleep avoids treating every poor night as the same disorder. Research into behavioural treatment has also broadened care beyond sedating medication. Cognitive behavioural therapy for insomnia targets patterns that keep someone awake after an initial trigger has passed.
This history matters because treating a coexisting condition alone may not resolve a persistent sleep problem, and useful care is more than advice to relax.